Project Grant R01AG093913
Award Date 1/1/26
Completion Date 12/31/30
Dollars Obligated $657K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- This Project Grant award of $1,592,854.00 from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports research to understand the role of the tau protein in the development of Alzheimer's disease and related dementias. The central hypothesis is that pathogenic forms of tau represent a misregulation of tau's normal biological function as a scaffold for regulating signaling pathways. The research aims to define the effects of tau post-translational...
- This Project Grant award of $816,661.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to comprehensively map the impact of tau pathology on the proteome and measure the functional consequences in neurodegeneration associated with Alzheimer's disease and frontotemporal dementia. The project combines expertise in mass spectrometry-based proteomics and functional genomics to elucidate the molecular and cellular mechanisms by which pathological tau drives...
- This $130,302 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research at New York University School of Medicine to investigate the selective vulnerability of basal forebrain cholinergic neurons (BFCNs) to tau pathology in Alzheimer's disease (AD). The key products and services to be delivered include: Investigating the biochemical underpinnings and functional alterations of BFCNs with pathological tau accumulation using human induced...
- This federal Project Grant award, titled "Mapping Proteomic Changes of Tauopathy in Human Neurons", is funded by the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $717,709.00 and will be completed by March 31, 2030. The award is held by Weill Medical College of Cornell University and aims to use advanced proteomic and transcriptomic approaches to discover cellular mechanisms underlying the propagation of misfolded tau protein aggregates in human neurons,...
- This federal Project Grant award of $431,750.00 was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to Case Western Reserve University. The grant supports research to investigate the role of the CHCHD10 protein in regulating mitochondrial function and its potential impact on tau pathology in Alzheimer's disease (AD) and related dementias. The key objectives are to: 1) validate and extend CHCHD10's role in tau pathology in vivo and ex vivo, and...
- This federal Project Grant award of $3,672,952.00 from the National Institutes of Health (NIH) Aging Research program (CFDA 93.866) supports research by Brigham & Women's Hospital Inc. on the role of tRNA-derived fragments (TRFs) in tau pathology associated with Alzheimer's disease (AD) and related tauopathies. The research aims to characterize the small RNA landscape, with a focus on TRFs, at different stages of AD pathology, examine the RNA binding capacity of tau variants, and investigate...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $773,816 to the University of California, Irvine to conduct a research project titled "Cell-type-specific and Spatial Proteogenomics Analysis of Aberrant RNA Splicing and Misfolded Proteins in Alzheimer's Related Tauopathies". The project aims to use advanced spatial proteogenomics techniques to map aberrant RNA splicing and abnormal protein products in specific brain...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $433,125 will fund a study to investigate the relationship between microglia, neurons, and tau pathology in Alzheimer's disease. The research will utilize a novel model system of microglial co-cultures with hippocampal assembloids derived from patient-derived induced pluripotent stem cell (iPSC) lines with MAPT mutations and healthy controls. The goal is to explore how bidirectional changes...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,489,452 to the University of California, Irvine to investigate the circuit vulnerability of the lateral and medial entorhinal cortices in Alzheimer's disease tauopathy models. The research aims to characterize the activity of memory-supporting neural circuits compromised by Alzheimer's disease and identify neuronal subtypes impacted during disease progression. The project is...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports comprehensive proteogenomic profiling of aberrant and mis-processed proteins in Alzheimer's disease (AD) and tauopathy models. The $784,596 grant aims to develop a state-of-the-art proteogenomic pipeline to globally profile disease-associated proteins, including those with amino acid substitutions, alternative isoforms, post-translational modifications, and proteolytic cleavage products. The...